Connecticut's economy bounced back from a sluggish start to the year to produce one of the fastest Q2 growth rates.

Among patients in a lung cancer screening registry, cancer survivors had similar outcomes as those with no prior cancer — but their rate of lung cancer detection was numerically higher. Cancer ...

The draft decision that was the subject of the hearing reduces a $105 million rate increase the utility asked for in Nov. 2024 to $28.25 million.

An artificial intelligence (AI) pipeline developed at a Montreal-based cancer center has shown promise in detecting extranodal extension (ENE) from standard CT scans in patients with HPV-positive ...

State legislators are preparing for a special session before Halloween as advocates and lawmakers are battling over state spending, affordable housing, and setting aside money to cover federal ...

One employee who recently retired said "in my 27 years, I have never seen morale as low as it is now. The lack of respect and negativity I observed is disheartening." ...

The copy-and-paste shutdown message broadcast by several executive branch agency chiefs earlier this week affected more parts of the government than previously understood. Treasury Department ...

Parker’s typical blitz rate is below 20%. In Iowa’s first two games, according to Pro Football Focus, Iowa blitzed on 26% of opponent drop-backs (15 of 57). But in the last three games, Iowa’s blitz ...

The University of Connecticut’s annual Fall Career Fair ran on Monday, Sept. 29 in the Student Union. Hundreds of students eager for summer internships and job opportunities buzzed around, the rooms ...

The UConn Huskies (3-2) are in the midst of a two-game winning streak and are beginning to find their momentum. A narrow 31-25 win over Ball State was followed ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $71.17, a high estimate of $78.00, and a low estimate of $65.00. Witnessing a positive shift, ...

The Company will present the reported topline results from its phase 3 SHIELD II trial at one of the world’s leading surgical conferencesPETACH TIKVA, Israel, Sept. 30, 2025 (GLOBE NEWSWIRE) -- ...